Letter: Adoption of Uniform Nomenclature Is Crucial for Estimating the True Risk of HBV Reactivation in Patients Treated With Direct-Acting Antivirals for Hepatitis C
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14653
Full Text
Open PDFAbstract
Available in full text
Date
May 17, 2018
Authors
Publisher
Wiley